Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Xiao-long WU; Hai-feng ZHUANG; Yan-na ZHAO; Xiao-ling YU; Tie-ying DAI; Rui-lan GAO

doi:10.1007/s11655-020-3252-y

Your Location：

Home >

Browse articles >

Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Feature Article | Updated：2021-08-23

- Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
- Chinese Journal of Integrative Medicine Vol. 26, Issue 5, Pages: 324-329(2020)
- Affiliations：
  
  Institute of Hematology Research, the First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou (310006), China
- Author bio：
  
  Correspondence to: Prof. GAO Rui-lan, E-mail:gaoruilan@126.com
- Funds：
- DOI：10.1007/s11655-020-3252-y
  CLC：
- Published：01 May 2020，
  
  Accepted：13 December 2019
Scan for full text
Xiao-long WU, Hai-feng ZHUANG, Yan-na ZHAO, et al. Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. [J]. Chinese Journal of Integrative Medicine 26(5):324-329(2020)
DOI：

Xiao-long WU, Hai-feng ZHUANG, Yan-na ZHAO, et al. Chinese Medicine Treatment on Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. [J]. Chinese Journal of Integrative Medicine 26(5):324-329(2020) DOI： 10.1007/s11655-020-3252-y.

摘要

Abstract

Graft-versus-host disease (GVHD) is the most common complication after allogeneic hematopoietic stem cell transplantation

and also an important factor affecting the survival and quality of life in patients after transplantation. Currently

immunosuppressive therapy is commonly used for GVHD

but the curative effect is not ideal. How to effectively prevent and treat GVHD is one of the difficulties to be solved urgently in the field of transplantation. In this paper

we summarize the latest progress in pathogenesis

prevention and treatment of GVHD with Chinese medicine (CM). We hope it will provide ideas and methods for exploring the mechanism and establishing a new comprehensive therapy for GVHD with CM.

关键词

Keywords

Chinese medicinehematopoietic stem cell transplantationgraftversus-host disease

references

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Chinese Medicine Regulates DNA Methylation to Treat Haematological Malignancies: A New Paradigm of “State-Target Medicine”

Related Author

No data

Related Institution

Key Laboratory of Shaanxi Administration of Traditional Chinese Medicine for TCM Compatibility, Shaanxi University of Chinese Medicine

State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Faculty of Medicine and Life Science, Xiamen University

Fujian Pien Tze Huang Enterprise Key Laboratory of Natural Medicine Research and Development

Department of General Surgery, First People's Hospital of Hangzhou Lin'an District

Institute of Chinese Medicine, The Chinese University of Hong Kong

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰